Werewolf Therapeutics Inc. Stock Price, News, Quote & History

Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.

Werewolf Therapeutics Inc.

Werewolf Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Werewolf Therapeutics Receives Fast Track Designation from the U.S. FDA for WTX-124, an Investigational Therapy for the Treatment of Cancer

Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer's 40th Annual Meeting

Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference

Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

5 US Longevity and Anti-aging Stocks to Watch in 2025

Stem Cell Stocks: 10 Biggest NASDAQ Companies in 2025

Latest News

Horn Island Project Update

Blue Star Gold Announces Closing of First Tranche of Non-Brokered Private Placement

Sankamap Updates Status on Late Filing of Financial Statements

Drilling contractors engaged for Sybella-Barkly targets

Drilling Underway at McDermitt Lithium Project

Latest News

Outlook Reports

Featured Biotech Investing Stocks

Browse Companies